are glp 1 drugs dangerous GLP-1 Safety Check Metabolic surgery and GLP-1 agonists
Description
Greco EV, Russo G, Giandalia A, Viazzi F, Pontremoli R, De Cosmo S
Contact us or book an appointment today for more information
These actions go beyond glycemic control, positioning them as potential therapeutic agents for diseases in which inflammation plays a central pathogenic role (Drucker 2018)
Onceweekly albiglutide versus oncedaily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, openlabel, multicentre, noninferiority phase 3 study
